IMTX
Price
$10.17
Change
+$0.08 (+0.79%)
Updated
Oct 14 closing price
Capitalization
1.24B
34 days until earnings call
Intraday Buy/Sell Signals
RLAY
Price
$6.03
Change
-$0.24 (-3.83%)
Updated
Oct 14 closing price
Capitalization
1.04B
21 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

IMTX vs RLAY

Header iconIMTX vs RLAY Comparison
Open Charts IMTX vs RLAYBanner chart's image
Immatics
Price$10.17
Change+$0.08 (+0.79%)
Volume$579.91K
Capitalization1.24B
Relay Therapeutics
Price$6.03
Change-$0.24 (-3.83%)
Volume$1.57M
Capitalization1.04B
IMTX vs RLAY Comparison Chart in %
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMTX vs. RLAY commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMTX is a Hold and RLAY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (IMTX: $10.17 vs. RLAY: $6.03)
Brand notoriety: IMTX and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMTX: 59% vs. RLAY: 105%
Market capitalization -- IMTX: $1.24B vs. RLAY: $1.04B
IMTX [@Biotechnology] is valued at $1.24B. RLAY’s [@Biotechnology] market capitalization is $1.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMTX’s FA Score shows that 0 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • IMTX’s FA Score: 0 green, 5 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMTX’s TA Score shows that 6 TA indicator(s) are bullish while RLAY’s TA Score has 3 bullish TA indicator(s).

  • IMTX’s TA Score: 6 bullish, 4 bearish.
  • RLAY’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, IMTX is a better buy in the short-term than RLAY.

Price Growth

IMTX (@Biotechnology) experienced а +8.08% price change this week, while RLAY (@Biotechnology) price change was +3.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Reported Earning Dates

IMTX is expected to report earnings on Nov 18, 2025.

RLAY is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMTX($1.24B) has a higher market cap than RLAY($1.04B). RLAY YTD gains are higher at: 46.359 vs. IMTX (43.038). IMTX has higher annual earnings (EBITDA): -58.05M vs. RLAY (-338.15M). RLAY has more cash in the bank: 657M vs. IMTX (478M). IMTX has less debt than RLAY: IMTX (17.1M) vs RLAY (34.2M). IMTX has higher revenues than RLAY: IMTX (130M) vs RLAY (8.36M).
IMTXRLAYIMTX / RLAY
Capitalization1.24B1.04B119%
EBITDA-58.05M-338.15M17%
Gain YTD43.03846.35993%
P/E Ratio29.35N/A-
Revenue130M8.36M1,556%
Total Cash478M657M73%
Total Debt17.1M34.2M50%
FUNDAMENTALS RATINGS
IMTX: Fundamental Ratings
IMTX
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
55
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMTXRLAY
RSI
ODDS (%)
Bearish Trend 8 days ago
76%
Bearish Trend 8 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 8 days ago
76%
Bearish Trend 8 days ago
90%
Momentum
ODDS (%)
Bullish Trend 10 days ago
74%
Bullish Trend 8 days ago
73%
MACD
ODDS (%)
Bullish Trend 9 days ago
73%
N/A
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 8 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 8 days ago
76%
Bullish Trend 8 days ago
75%
Advances
ODDS (%)
Bullish Trend 8 days ago
77%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend about 1 month ago
79%
Bearish Trend 23 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
90%
Aroon
ODDS (%)
Bullish Trend 8 days ago
74%
Bullish Trend 8 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PASVX55.800.84
+1.53%
T. Rowe Price Small-Cap Value Adv
TSFCX12.430.17
+1.39%
Touchstone Small Cap C
SDFSX18.810.20
+1.07%
Sit Small Cap Dividend Growth S
IVFAX4.35N/A
N/A
Federated Hermes Intl Strat Val Div A
ITYYX76.59-1.28
-1.64%
Invesco Technology Y

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with IDYA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
+0.79%
IDYA - IMTX
52%
Loosely correlated
+1.12%
XNCR - IMTX
49%
Loosely correlated
-10.96%
IMNM - IMTX
49%
Loosely correlated
-1.05%
NRIX - IMTX
48%
Loosely correlated
-5.56%
RLAY - IMTX
48%
Loosely correlated
-3.83%
More